SIR ePoster Library

685 - Direct versus total serum bilirubin: Which is the better predictor of survival in patients undergoing transarterial therapies for hepatocellular carcinoma?
SIR ePoster library. Gabr A. 03/28/20; 289926; 685
Ahmed Gabr
Ahmed Gabr
Login now to access Regular content available to all registered users.
Abstract
Discussion Forum (0)
Rate & Comment (0)
Poster Title: Direct versus total serum bilirubin: Which is the better predictor of survival in patients undergoing transarterial therapies for hepatocellular carcinoma?

Poster number: 685

Category: Arterial Interventions: Embolization

Authors: A Gabr1, Y Jahangiri2, K Yamada2, B Uchida3, J Li4, J Edwards4, K Farsad2

Keywords: 0685, Ahmed Gabr Direct versus total serum bilirubin: Which is the better predictor of survival in patients undergoing transarterial therapies for hepatocellular carcinoma? Direct versus total serum bilirubin: Which is
Poster Title: Direct versus total serum bilirubin: Which is the better predictor of survival in patients undergoing transarterial therapies for hepatocellular carcinoma?

Poster number: 685

Category: Arterial Interventions: Embolization

Authors: A Gabr1, Y Jahangiri2, K Yamada2, B Uchida3, J Li4, J Edwards4, K Farsad2

Keywords: 0685, Ahmed Gabr Direct versus total serum bilirubin: Which is the better predictor of survival in patients undergoing transarterial therapies for hepatocellular carcinoma? Direct versus total serum bilirubin: Which is
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies